Medicare Enrolled

Dr. Christine Crisostomo

Nurse Practitioner - Family · Bakersfield, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
500 WINDSOR PARK DR, Bakersfield, CA 93311
6614722075
In practice since 2020 (6 years)
NPI: 1831739226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crisostomo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crisostomo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Crisostomo

Dr. Christine Crisostomo is a nurse practitioner - family in Bakersfield, CA, with 6 years of NPI registration. Based on federal Medicare data, Dr. Crisostomo performed 530 Medicare services across 332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Crisostomo received a total of $4,483 from 33 pharmaceutical and/or device companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Crisostomo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years in practice ▲ Top 24% volume in CA $4,483 industry payments

Medicare Practice Summary

Medicare Utilization ↗
530
Medicare services
Top 24% in CA for nurse practitioner - family
332
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
128 $87 $203
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
105 $0 $19
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
66 $0 $30
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
60 $10 $63
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
44 $0 $25
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $99 $329
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
34 $2 $34
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
32 $35 $100
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
19 $23 $155
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,483
Total received (2021-2024)
Avg $1,121/year across 4 years
Top 5% in CA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
113
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,483 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$119
2023
$1,200
2022
$770
2021
$2,394

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$119
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2021-2024) ›
GlaxoSmithKline, LLC.
$735
Amgen Inc.
$366
AstraZeneca Pharmaceuticals LP
$299
Novo Nordisk Inc
$259
Lilly USA, LLC
$237
Biohaven Pharmaceuticals, Inc.
$204
Boehringer Ingelheim Pharmaceuticals, Inc.
$168
Nevro Corp.
$158
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$139
Merck Sharp & Dohme Corporation
$137
Medtronic, Inc.
$135
Otsuka America Pharmaceutical, Inc.
$128
Dexcom, Inc.
$124
Merck Sharp & Dohme LLC
$124
IDORSIA PHARMACEUTICALS US INC
$122
Incyte Corporation
$115
AbbVie Inc.
$114
Regeneron Healthcare Solutions, Inc.
$110
Abbott Laboratories
$102
Bayer Healthcare Pharmaceuticals Inc.
$89
Janssen Pharmaceuticals, Inc
$88
DEXCOM, INC.
$84
Insulet Corporation
$81
Neurocrine Biosciences, Inc.
$80
Phadia US Inc.
$69
Amarin Pharma Inc.
$56
Novartis Pharmaceuticals Corporation
$37
Nestle HealthCare Nutrition Inc.
$34
PFIZER INC.
$24
CMP Pharma, Inc.
$18
MannKind Corporation
$17
SANOFI-AVENTIS U.S. LLC
$16
Smith+Nephew, Inc.
$15
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AREXVY · Aimovig · BELSOMRA · BREZTRI · COLLAGENASE SANTYL · COLOGUARD DNA CAPTURE REAGENTS · Carospir · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DUPIXENT · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · INGREZZA · ImmunoCAP · InPen · JARDIANCE · Kerendia · LINZESS · MONJUVI · MOUNJARO · Minimed 770G System · NURTEC ODT · ORIAHNN · Omnipod · Otezla · Ozempic · Prolia · QUVIVIQ · REXULTI · RYBELSUS · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · Senza · TRADJENTA · TRELEGY ELLIPTA · TRIJARDY XR · TRULANCE · UBRELVY · VERQUVO · Vascepa · VenaSeal · XARELTO · XIFAXAN · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for nurse practitioner - family in CA.

Looking for a nurse practitioner - family in Bakersfield?
Compare family nurse practitioners in the Bakersfield area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
323
Per 100K population
35.5
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
14.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Crisostomo is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement in the top 5% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Crisostomo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Crisostomo performed 128 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crisostomo receive payments from pharmaceutical companies?
Yes. Dr. Crisostomo received a total of $4,483 from 33 companies across 113 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crisostomo's costs compare to other family nurse practitioners in Bakersfield?
Dr. Crisostomo's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crisostomo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →